Literature DB >> 19924735

Intravenous contrast ultrasound examination using contrast-tuned imaging (CnTI) and the contrast medium SonoVue for discrimination between benign and malignant adnexal masses with solid components.

A C Testa1, D Timmerman, V Van Belle, E Fruscella, C Van Holsbeke, L Savelli, E Ferrazzi, F P G Leone, H Marret, F Tranquart, C Exacoustos, G Nazzaro, D Bokor, F Magri, S Van Huffel, G Ferrandina, L Valentin.   

Abstract

OBJECTIVE: To determine whether intravenous contrast ultrasound examination is superior to gray-scale or power Doppler ultrasound for discrimination between benign and malignant adnexal masses with complex ultrasound morphology.
METHODS: In an international multicenter study, 134 patients with an ovarian mass with solid components or a multilocular cyst with more than 10 cyst locules, underwent a standardized transvaginal ultrasound examination followed by contrast examination using the contrast-tuned imaging technique and intravenous injection of the contrast medium SonoVue(R). Time intensity curves were constructed, and peak intensity, area under the intensity curve, time to peak, sharpness and half wash-out time were calculated. The sensitivity and specificity with regard to malignancy were calculated and receiver-operating characteristics (ROC) curves were drawn for gray-scale, power Doppler and contrast variables and for pattern recognition (subjective assignment of a certainly benign, probably benign, uncertain or malignant diagnosis, using gray-scale and power Doppler ultrasound findings). The gold standard was the histological diagnosis of the surgically removed tumors.
RESULTS: After exclusions (surgical removal of the mass > 3 months after the ultrasound examination, technical problems), 72 adnexal masses with solid components were used in our statistical analyses. The values for peak contrast signal intensity and area under the contrast signal intensity curve in malignant tumors were significantly higher than those in borderline tumors and benign tumors, while those for the benign and borderline tumors were similar. The area under the ROC curve of the best contrast variable with regard to diagnosing borderline or invasive malignancy (0.84) was larger than that of the best gray-scale (0.75) and power Doppler ultrasound variable (0.79) but smaller than that of pattern recognition (0.93).
CONCLUSION: Findings on ultrasound contrast examination differed between benign and malignant tumors but there was a substantial overlap in contrast findings between benign and borderline tumors. It appears that ultrasound contrast examination is not superior to conventional ultrasound techniques, which also have difficulty in distinguishing between benign and borderline tumors, but can easily differentiate invasive malignancies from other tumors. Copyright 2009 ISUOG. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19924735     DOI: 10.1002/uog.7464

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  12 in total

1.  Parametric mapping of contrasted ovarian transvaginal sonography.

Authors:  Katrina Korhonen; Ryan Moore; Andrej Lyshchik; Arthur C Fleischer
Journal:  Ultrasound Q       Date:  2015-06       Impact factor: 1.657

Review 2.  Diagnosis, treatment, and follow-up of borderline ovarian tumors.

Authors:  Daniela Fischerova; Michal Zikan; Pavel Dundr; David Cibula
Journal:  Oncologist       Date:  2012-09-28

3.  Role of ultrasonography and contrast-enhanced ultrasonography in a case of Krukenberg tumor.

Authors:  Paola Tombesi; Francesca Di Vece; Francesca Ermili; Fabio Fabbian; Sergio Sartori
Journal:  World J Radiol       Date:  2013-08-28

4.  Endometriosis Increases the Risk of Placenta Previa in Both IVF Pregnancies and the General Obstetric Population.

Authors:  Eider Gómez-Pereira; Jorge Burgos; Rosario Mendoza; Irantzu Pérez-Ruiz; Fátima Olaso; David García; Iker Malaina; Roberto Matorras
Journal:  Reprod Sci       Date:  2022-08-23       Impact factor: 2.924

5.  Early detection of ovarian cancer with conventional and contrast-enhanced transvaginal sonography: recent advances and potential improvements.

Authors:  Arthur C Fleischer; Andrej Lyshchik; Makiko Hirari; Ryan D Moore; Richard G Abramson; David A Fishman
Journal:  J Oncol       Date:  2012-04-26       Impact factor: 4.375

Review 6.  Ultrasound evaluation of ovarian masses and assessment of the extension of ovarian malignancy.

Authors:  Francesca Moro; Rosanna Esposito; Chiara Landolfo; Wouter Froyman; Dirk Timmerman; Tom Bourne; Giovanni Scambia; Lil Valentin; Antonia Carla Testa
Journal:  Br J Radiol       Date:  2021-06-09       Impact factor: 3.629

7.  A preliminary study: The sequential use of the risk malignancy index and contrast-enhanced ultrasonography in differential diagnosis of adnexal masses.

Authors:  Li Qiu; Fan Yang; Hong Luo
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

8.  Contrast-enhanced ultrasound in ovarian tumors - diagnostic parameters: method presentation and initial experience.

Authors:  Anita-Roxana Maxim; Radu Badea; Atilla Tamas; Alexandru Traila
Journal:  Clujul Med       Date:  2013-02-04

9.  The contribution of qualitative CEUS to the determination of malignancy in adnexal masses, indeterminate on conventional US - a multicenter study.

Authors:  Xinling Zhang; Yongjiang Mao; Rongqin Zheng; Zhijuan Zheng; Zeping Huang; Dongmei Huang; Jing Zhang; Qing Dai; Xiaodong Zhou; Yanling Wen
Journal:  PLoS One       Date:  2014-04-15       Impact factor: 3.240

Review 10.  Role of contrast-enhanced ultrasound (CEUS) in the diagnosis of endometrial pathology.

Authors:  Ciprian Mihaita Pop; Dan Mihu; Radu Badea
Journal:  Clujul Med       Date:  2015-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.